F-1/A: HW Electro Files Amended F-1 to Detail Underwriting Agreement for Proposed US Public Offering
Amendment to Registration Statement for Public Offering
HW Electro Co., Ltd. has filed an Amendment No. 2 to its F-1 Registration Statement, primarily to include the form of Underwriting Agreement for its proposed public offering of 4,150,000 American Depositary Shares, with an option for an additional 622,500 ADSs.
Summary
- HW Electro Co., Ltd., a Japanese joint-stock corporation, filed Amendment No. 2 to its Form F-1 Registration Statement (originally filed May 9, 2025) as an exhibit-only filing.
- The primary purpose of this amendment is to file the form of Underwriting Agreement (Exhibit 1.1) for its proposed public offering.
- The company proposes to issue and sell an aggregate of 4,150,000 American Depositary Shares (ADSs), each representing one ordinary share (Firm Securities).
- The Underwriters have an option to purchase up to an additional 622,500 ADSs (Option Securities).
- The ADSs will be issued pursuant to a Deposit Agreement with Citibank, N.A. as the Depositary.
- The Purchase Price per ADS, Underwriting Discount per ADS, and Proceeds to Company per ADS (before expenses) are currently placeholders in the agreement.
- The company has a history of issuing unregistered securities, including 2,312,500 Ordinary Shares for JPY185 million on June 30, 2021, and 1,428,571 Series A convertible preferred shares for JPY99.99997 million on October 20, 2021, among other issuances totaling over JPY1.7 billion between June 2021 and April 2023.
- A 1-for-2 share split of Ordinary Shares and Series A convertible preferred shares was effective September 1, 2023, resulting in 38,074,888 Ordinary Shares and 2,857,142 Series A convertible preferred shares outstanding post-split.
- On August 31, 2023, Autobacs Seven converted its 2,857,142 Series A convertible preferred shares into Ordinary Shares, which were subsequently canceled on October 20, 2023.
- The company will indemnify the Underwriters against certain liabilities and will pay all costs and expenses incident to the offering, including a non-accountable expense allowance of 1% of the gross proceeds.
- Officers, directors, and certain 10% shareholders of the company are subject to a 12-month lock-up period from the date of the final prospectus, restricting the sale or transfer of their securities, with specific exceptions.
Sentiment
Score: 6
Explanation: The document is a procedural amendment for a proposed public offering, indicating progress towards a capital raise. While it doesn't contain financial results, the initiation of an IPO process is generally a positive step for a company seeking growth capital. The placeholder values for pricing and the delay undertaking are neutral aspects, reflecting the ongoing nature of the process.
Positives
- The filing indicates active progress towards a public offering, which is a crucial step for the company to raise significant capital for its operations and growth.
- The company has secured reputable underwriters, WestPark Capital, Inc. and American Trust Investment Services, for the offering.
- The proposed listing of ADSs on Nasdaq will provide increased liquidity and visibility for the company's shares.
- The company has a track record of successfully raising capital through private placements prior to this public offering attempt.
Negatives
- The specific pricing details (Purchase Price, Underwriting Discount, Net Proceeds) are still placeholders, indicating that the final terms of the offering are not yet determined.
- The 12-month lock-up period for officers, directors, and certain shareholders restricts their ability to sell shares, potentially limiting liquidity for these key stakeholders.
- The company is undertaking significant financial obligations related to the offering, including underwriting fees, expenses, and indemnification liabilities.
- The F-1/A filing itself is an amendment to delay the effective date, suggesting the IPO process is still in a preparatory phase and not yet finalized for public sale.
Risks
- The offering may be terminated by the Representatives under certain adverse market conditions, including suspension of trading on major exchanges, a general moratorium on commercial banking activities, or significant financial market changes or calamities.
- Indemnification for liabilities arising under the Securities Act, as provided in the Underwriting Agreement, may be deemed against public policy by the SEC and could be unenforceable.
- The company is subject to ongoing compliance requirements with the Securities Act and Exchange Act, including filing post-effective amendments and periodic reports, which require significant resources and adherence to complex regulations.
- The company's status as an Emerging Growth Company (EGC) or Foreign Private Issuer (FPI) may change, potentially altering its regulatory compliance obligations.
- The company's financial statements, particularly unaudited interim statements, are subject to normal year-end audit adjustments and the exclusion of certain footnotes, which could lead to changes in reported financial information.
- There is a risk of legal, governmental, or regulatory investigations, actions, demands, claims, suits, arbitrations, inquiries, or proceedings that could have a Material Adverse Effect if determined adversely to the company.
- Risks related to intellectual property, including potential infringement, misappropriation, or violations by the company, or infringement of the company's intellectual property by others.
- The company faces risks associated with compliance with various laws and regulations, including anti-bribery, anti-corruption, anti-money laundering, and sanctions laws.
- Cybersecurity and data protection risks exist, including potential breaches, outages, or unauthorized access to the company's IT Systems and Personal Data.
- While the company does not expect to be a passive foreign investment company (PFIC) for its current taxable year, this determination cannot be made until year-end, posing a potential future tax risk to investors.
- The enforceability of U.S. federal or New York state court judgments against the company in Japanese courts is subject to compliance with relevant Japanese civil law and rules of civil procedures.
- The choice of New York law as the governing law for the Transaction Documents, while valid under Japanese law, is subject to restrictions on the enforceability of civil liabilities as described in the prospectus.
Future Outlook
The company intends to apply the net proceeds from the sale of the Offered Securities as described in the Registration Statement, Pricing Disclosure Package, and Prospectus under the heading 'Use of proceeds'. The company does not expect to be a passive foreign investment company (PFIC) for its current taxable year, though a final determination cannot be made until the end of the taxable year. The company will use its reasonable best efforts to list the Offered Securities for quotation on Nasdaq.
Management Comments
- "The Registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the registration statement shall become effective on such date as the U.S. Securities and Exchange Commission, acting pursuant to such Section 8(a), may determine."
- "The Company will apply the net proceeds from the sale of the Offered Securities as described in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus under the heading Use of proceeds."
Industry Context
This document is a procedural SEC filing related to a proposed public offering and does not contain specific analysis of broader industry trends or the company's competitive position within its industry.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
Legal Proceedings
- The company represents that, except as described in the Registration Statement, Pricing Disclosure Package, and Prospectus, there are no pending or threatened legal, governmental, or regulatory investigations, actions, demands, claims, suits, arbitrations, inquiries, or proceedings that could reasonably be expected to have a Material Adverse Effect.
Stakeholder Impact
- Shareholders: Existing shareholders, particularly officers, directors, and 10% holders, will be subject to a 12-month lock-up period, restricting their ability to sell shares. New investors will gain liquidity through the proposed Nasdaq listing.
- Company: The company will receive capital from the offering, which will be used as described in the prospectus, potentially funding growth and operations. It will incur significant offering-related expenses and liabilities.
- Underwriters: The underwriters will earn underwriting discounts and commissions, and will be reimbursed for certain expenses, while also being indemnified by the company against specific liabilities related to the offering.
Next Steps
- The company will file the final Prospectus with the Commission within the time periods specified by Rule 424(b) and Rule 430A, 430B or 430C under the Securities Act.
- The company will file any Issuer Free Writing Prospectus to the extent required by Rule 433 under the Securities Act.
- The company will promptly file all reports and any definitive proxy or information statements required by the Exchange Act subsequent to the date of the Prospectus.
- The company will furnish copies of the Prospectus and each Issuer Free Writing Prospectus to the Underwriters.
- The company will qualify the Offered Securities for offer and sale under the securities or Blue Sky laws of requested jurisdictions.
- The company will make generally available to its security holders and the Representatives an earning statement satisfying Section 11(a) of the Securities Act and Rule 158.
- The company will use its reasonable best efforts to list the Offered Securities for quotation on Nasdaq.
- The company will promptly notify the Representatives if it ceases to be an Emerging Growth Company or a Foreign Private Issuer.
- The company will pay the required Commission filing fees relating to the ADSs.
- The Underwriters may exercise their option to purchase Option Securities at any time in whole, or from time to time in part, on or before the forty-fifth (45th) day following the date of the Prospectus.
Key Dates
| Date | Description |
|---|---|
| June 30, 2021 | Company issued 2,312,500 Ordinary Shares to six investors for JPY185 million. |
| October 20, 2021 | Company issued 1,428,571 Series A convertible preferred shares to one accredited investor for JPY99.99997 million. |
| December 28, 2021 | Company issued 975,000 Ordinary Shares to nine investors for JPY195 million. |
| February 28, 2022 | Company issued 200,000 Ordinary Shares to one investor for JPY70 million. |
| March 28, 2022 | Company issued 242,858 Ordinary Shares to two investors for JPY85.0003 million. |
| December 15, 2022 | Company issued 215,718 Ordinary Shares to seven investors for JPY75.5013 million. |
| January 31, 2023 | Company issued 571,930 Ordinary Shares to one accredited investor for JPY114.386 million. |
| February 28, 2023 | Company issued 857,143 Ordinary Shares to one accredited investor for JPY300.00005 million. |
| March 29, 2023 | Company issued 40,000 Ordinary Shares to one investor for JPY20 million. |
| March 30, 2023 | Company issued 40,000 Ordinary Shares to two investors for JPY20 million. |
| March 31, 2023 | Company issued 1,735,724 Ordinary Shares to 25 investors for JPY607.5034 million. |
| April 1, 2023 | Company issued 20,000 Ordinary Shares to one investor for JPY10 million. |
| April 3, 2023 | Company issued 20,000 Ordinary Shares to one investor for JPY10 million. |
| April 10, 2023 | Company issued 200,000 Ordinary Shares to one accredited investor for JPY100 million. |
| April 11, 2023 | Company issued 20,000 Ordinary Shares to one investor for JPY10 million. |
| April 12, 2023 | Company issued 20,000 Ordinary Shares to one investor for JPY10 million. |
| April 24, 2023 | Company issued 92,000 Ordinary Shares to one investor for JPY46 million. |
| April 25, 2023 | Company issued 6,000 Ordinary Shares to one investor for JPY3 million. |
| April 28, 2023 | Company issued 40,000 Ordinary Shares to one investor for JPY20 million. |
| July 20, 2023 | Company's board of directors approved a 1-for-2 share split of Ordinary Shares and Series A convertible preferred shares. |
| August 31, 2023 | Record date for the share split; Autobacs Seven requested conversion of its 2,857,142 Series A convertible preferred shares. |
| September 1, 2023 | The 1-for-2 share split became effective. |
| October 20, 2023 | The 2,857,142 Series A convertible preferred shares acquired from Autobacs Seven were canceled by the company. |
| May 9, 2025 | Original F-1 Registration Statement (Registration No. 333-287112) was filed. |
| June 23, 2025 | Amendment No. 2 to Form F-1 was filed with the U.S. Securities and Exchange Commission. |
Keywords
HW Electro, SEC Filing, F-1/A, Underwriting Agreement, Public Offering, IPO, American Depositary Shares, ADSs, Ordinary Shares, Securities Act, Capital Raise, Japan, Lock-up Agreement, Emerging Growth Company, Foreign Private Issuer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.